Galenpharma

What Galenpharma does

GALENpharma GmbH is a German family-owned pharmaceutical company founded in 1985 in Kiel by Dr. med. Otto Paulsen and his son, pharmacist Jan Paul Paulsen. The company specializes in galenic formulations — the science of compounding drugs into usable dosage forms — and is headquartered at Wittland 13, Kiel. Its stated core competency is corticosteroids, where it claims the broadest range of formulations in Germany spanning topical (creams, ointments, solutions, lotions, gels), oral (tablets, soft capsules), nasal sprays, and parenteral (injectable) presentations. Beyond corticosteroids, the portfolio covers dermatology (HydroGalen hydrocortisone cream, ClotriGalen clotrimazole antifungal cream and pumpspray, Amofin amorolfine nail lacquer), allergy (MomeAllerg mometasone nasal spray, DuoAllerg azelastine/fluticasone combination spray), local anesthesia (LIDOGALEN lidocaine cream, Lidoproct lidocaine rectal ointment), testosterone replacement therapy, and vitamin D supplementation (Vit. D3 GALEN).

The company sells both prescription (Rx) and over-the-counter (OTC) medications through the German public pharmacy (Apotheken) channel, with no documented exports beyond the DACH region. It targets healthcare professionals — physicians and pharmacists — as selection partners, providing product information through a DocCheck-protected Fachkreise (HCP) portal in compliance with German pharmaceutical advertising regulations. End users are patients in dermatology, urology, endocrinology, allergology, orthopedics, pediatrics, oncology, and general practice. Marketing is supported by Google Ads, Matomo web analytics, Google Tag Manager, and Proven Expert review management.

The business model is straightforward pharmaceutical product sales through wholesale-to-pharmacy distribution. Pricing is determined by German pharmaceutical market regulations rather than company-set pricing, and is not publicly disclosed. Revenue figures are not disclosed; the company is privately held with no external funding, no parent company, no subsidiaries, no M&A history, and no public financial reporting. Current management comprises Jan Paul Paulsen (founder's son, managing director) and Dr. Hanns Soblik (representative). Headcount is in the 11–50 range.

Name

Galenpharma

Legal name

GALENpharma GmbH

Website

https://galenpharma.de

Company type

Private

Founded year

1985

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Dermatological Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Dermatology & Topical Skin Treatments (HLAIADAE)

akta.pro secondary industries

Allergy, Sinus & Respiratory (Non-Asthma) (HLAIADAC), Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal) (CRADAMAF), Topical & Dermatology Generics (HLAIABAE)

Keywords

• Topical corticosteroids
• Dermatological products
• Galenic formulations
• Pharmaceutical manufacturing
• Allergy medications

Headquarters

HQ city

Kiel

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Pharmaceutical product sales: GALENpharma generates revenue through the development, manufacturing, and supply of pharmaceutical medications. Their product portfolio includes prescription (Rx) and over-the-counter (OTC) medications distributed through public pharmacies in Germany. The company offers a broad range of topical, oral, and parenteral medications primarily focused on corticosteroids, dermatological products, allergy treatments, testosterone preparations, and essential dermatological treatments.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

GALENpharma GmbH develops, manufactures, and distributes topical, oral, and parenteral pharmaceutical medications in Germany. Its core competency is galenic formulations, with the broadest range of corticosteroid formulations in Germany covering creams, ointments, solutions, lotions, gels, tablets, soft capsules, nasal sprays, and injectables. The portfolio additionally includes dermatological products, allergy treatments, testosterone preparations, antifungal medications, local anesthetics, and vitamin D supplements, available as both prescription (Rx) and over-the-counter (OTC) products.

Product overview

GALENpharma GmbH is a German pharmaceutical company founded in 1985, based in Kiel, specializing in the development, manufacture, and distribution of topical, oral, and parenteral medications. The company's core competencies lie in corticosteroids, with the broadest range of corticosteroid formulations in Germany, complemented by dermatological products, allergy treatments, testosterone preparations, and over-the-counter medications. The portfolio includes allergy treatments (MomeAllerg® NASENSPRAY, DuoAllerg® NASENSPRAY), anti-inflammatory dermatologicals (HydroGalen® akut CREME), antifungals (ClotriGalen® CREME/PUMPSPRAY, Amofin® Nagellack), local anesthetics (LIDOGALEN® CREME, Lidoproct® Rektalsalbe), and vitamin supplements (Vit. D3 GALEN®). The company markets through pharmacies and serves medical specialties including dermatology, urology, endocrinology, allergology, orthopedics, pediatrics, oncology, and general practice.

Differentiator

Problem solved

Functional benefit

Products and services

• MomeAllerg® NASENSPRAY Mometasone furoate nasal spray (50 µg/spray) for symptomatic treatment of seasonal allergic rhinitis in adults. Provides long-lasting relief with once-daily targeted nasal action.
• DuoAllerg® NASENSPRAY Combination nasal spray containing azelastine hydrochloride and fluticasone propionate for treatment of moderate to severe seasonal allergic rhinitis when monotherapy with an intranasal antihistamine or corticosteroid is insufficient.
• HydroGalen® akut CREME Hydrocortisone 5 mg/g anti-inflammatory cream for short-term (maximum 2 weeks) treatment of inflammatory, allergic, or pruritic skin conditions responding to mild topical corticosteroids.
• ClotriGalen® CREME Topical antifungal cream containing clotrimazole for treatment of skin fungal infections caused by dermatophytes, yeasts, and molds; also effective against Corynebacterium minutissimum.
• ClotriGalen® PUMPSPRAY Clotrimazole 10 mg/ml topical solution spray (40 ml) for treatment of skin fungal infections. Antifungal medication with broad-spectrum activity against fungi, yeasts, and bacteria.
• Amofin® Nagellack Nail lacquer containing 5% amorolfine hydrochloride for treatment of nail fungal infections. Waterproof, colorless lacquer with 7-day duration of action, applied once weekly.
• LIDOGALEN® CREME Topical anesthetic cream containing 40 mg/g lidocaine for pain control prior to minor procedures such as injections, microneedling, and tattoo removal. Provides approximately 2 hours of pain relief with 30-minute exposure time. Suitable for infants from 1 month of age.
• Lidoproct® Rektalsalbe Rectal ointment containing 50 mg/g lidocaine for localized treatment of pain and itching in the anal area, including hemorrhoids and anal fissures. Includes applicator for targeted application.
• Vit. D3 GALEN® 1.000 I.E. Colecalciferol (Vitamin D3) 1,000 I.E. soft capsule for treatment and prevention of vitamin D deficiency in adults and adolescents. Supports bone health and immune system function. Made from bovine gelatin (halal certified).

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• DocCheckcoreTechnology or IntegrationDocCheck provides healthcare professional authentication for GALENpharma's Fachkreise (professional) portal. Access to protected professional information requires DocCheck login credentials. This ensures compliance with regulations restricting certain product information to healthcare professionals only.

Scale indicators1 record

Recent moves3 records

Expansion highlights4 records

Direct peers

• Dermapharm Holding SE: German specialty pharmaceutical company with a strong focus on dermatology, allergy, and OTC products, very comparable to GALENpharma's therapeutic mix and German pharmacy channel.
• Kade Pharma / Besins Healthcare Germany: Mid-sized German specialty pharma with comparable dermatology, gynecology/urology, and OTC offerings distributed through German pharmacies.
• Strathmann GmbH & Co. KG: German specialty pharmaceutical company with overlapping dermatology and OTC product portfolios, distributed via the German pharmacy channel.
• Biologische Heilmittel Heel GmbH: German pharmaceutical manufacturer with a comparable dermatology and immunology-adjacent portfolio targeting physicians and pharmacies in Germany.
• Dr. August Wolff GmbH & Co. KG Arzneimittel: Mid-sized German specialty pharma with dermatology, gynecology, and OTC lines sold through German pharmacies — a close analogue in scale and channel.

Broad incumbents

• STADA Arzneimittel AG: Large German-headquartered generic and specialty pharma with a broad dermatology, allergy, and OTC portfolio overlapping GALENpharma's therapeutic areas via German pharmacy distribution.
• Hexal AG: Major German generics manufacturer (Sandoz/Novartis) active across dermatology, allergy, and OTC categories through the same Apotheken channel as GALENpharma.
• ratiopharm GmbH: Prominent German generics brand (Teva) competing in many of the same active ingredients (e.g., mometasone, hydrocortisone, clotrimazole) and the same pharmacy distribution channel.
• Bayer AG (Consumer Health / Dermatology): Diversified German incumbent with a strong dermatology and allergy OTC portfolio (e.g., Bepanthen, Claritin) competing directly with several GALENpharma SKUs in pharmacies.

Regional players

• Almirall S.A. European dermatology-focused specialty pharma with comparable therapeutic-area focus; serves Germany through affiliates and partners but is headquartered in Spain.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Galenpharma